Is the EU Biotech Act Europe’s Innovation Turning Point?

Is the EU Biotech Act Europe’s Innovation Turning Point?
Published in December 2025, the EU Biotech Act represents a major shift in Europe’s Innovation landscape and one of the most ambitious efforts in recent years to establish Europe as a global biotech hub. The newly proposed EU Biotech Act, combined with the Pharma Package's revised incentive model, acts as a catalyst to align biotech investment, infrastructure and regulation with Pharma reforms  In this session, we will examine key regulatory interventions proposed by the EU Biotech Act through a practical lens and at the intersection of other EU initiatives.


Sponsored by 

Date: Tuesday 19 May 2026
Time: 16:00 - 17:00 BST

What you'll learn

By attending, you'll gain:

  • A clear picture of Europe's current R&D and innovation landscape amid rising global competition and the economic forces driving this change
  • Practical insight into how the proposed reforms under the EU Biotech Act may translate into real-world considerations
  • A joined-up view of EU innovation policy in action, exploring how the EU Biotech Act intersects with broader initiatives such as the EU Pharma Package and Joint Clinical Assessments (JCAs)

Who should attend

This webinar is ideal for regulatory professionals seeking to understand the impact of the EU Biotech Act on regulatory strategy and innovation:

  • Regulatory Affairs and Regulatory Intelligence leaders
  • Heads and Directors of Regulatory Compliance
  • Regulatory Policy
  • Global and EU focused regulatory strategy teams
Especially relevant for teams responsible for navigating evolving EU regulatory frameworks.

Webinar host & presenters


 Host: Michael Ward
Global head of Thought Leadership, Clarivate
As both a journalist and analyst, Mike has been writing, analysing and commenting on the life sciences industry for more than 35 years. His actionable insights support pharma, biotech, healthcare and medtech stakeholders in understanding market trends.
 
 

Presenter: Sofia Ataide
Senior Business Solution Consultant, Clarivate

Sofia Ataide holds Masters degrees in Pharmaceutical Sciences from the University of Lisbon and International Health Management from Imperial College Business School. With nearly eight years at Clarivate, Sofia has worked across Sales and Marketing under the Cortellis Brand Portfolio. In her current role as Senior Solutions Consultant, she leverages deep domain expertise to interpret complex clinical, regulatory, and strategic requirements and translate them into integrated solution packages that best support customer needs. 

  Presenter: Nuala Moran

 
  Presenter TBC

Pricing

 Standard webinar registration fees
 Webinar Registration Type Price (GBP)
 Standard Price 
 TOPRA Member		 FREE
 Standard Price
 Non-member		 FREE






 

Invest in your expertise this year and save with TOPRA membership 

Advance your regulatory knowledge and broaden your professional expertise while making your development budget go further. 

Not yet a TOPRA member? Join today and benefit from ongoing savings that make membership a smart investment in your long-term growth. As a member, you’ll gain more than just discounts: you’ll access exclusive learning opportunities, expert insights, and a network of professionals shaping the future of regulatory affairs. Whether you take one course or all three, TOPRA membership helps you gain more from your development while spending less.

Join today

 

 
When
19/05/2026 16:00 - 17:00
Where
ONLINE
Sign in or create an account to register Registration ends 18/05/2026 16:00 (GMT Daylight Time)
My registration status: Not registered
Please complete your registration by adding any required items to your basket and proceeding to the checkout.
 
Your company name
Your VAT country
Your VAT number
NOTE
Important instructions before booking - If your company name or VAT number does not appear here or you would like to be invoiced using a different VAT number, please email finance@topra.org

Register now